EUVIMEDEUVIMED entdecken
Crossref

Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study

Justine Hugon-Rodin, Camille Carrière, Ségolène Claeyssens, Nathalie Trillot, Nicolas Drillaud, Christine Biron-Andreani, Cécile Lavenu-Bombled, Anna Wieland, Claire Flaujac, Natalie Stieltjes, Aurélien Lebreton, Thomas Brungs und 11 weitere

Journal of Thrombosis and Haemostasis · 2023-08 · 21 (8) · 2126-2136

DOI: 10.1016/j.jtha.2023.04.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-08. Verfasst von Justine Hugon-Rodin und 22 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Department, Gynecological Endocrinology Unit, Hospital Saint Joseph, INSERM UMR 1153, EPOPé Group, Paris, France; University Hospitals of …. Hauptthemen laut MEDLINE: Afibrinogenemia, Hemostatics, Postpartum Hemorrhage, Thrombosis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Novo Nordisk, CSL Behring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Women with hereditary fibrinogen disorders (HFDs) seem to be at an increased risk of adverse obstetrical outcomes, but epidemiologic data are limited. OBJECTIVES: We aimed to determine the prevalence of pregnancy complications; the modalities and management of delivery; and the postpartum events in women with hypofibrinogenemia, dysfibrinogenemia, and hypodysfibrinogenemia. METHODS: We conducted a retrospective and prospective multicentric international study. RESULTS: A total of 425 pregnancies were investigated from 159 women (49, 95, and 15 cases of hypofibrinogenemia, dysfibrinogenemia, and hypodysfibrinogenemia, respectively). Overall, only 55 (12.9%) pregnancies resulted in an early miscarriage, 3 (0.7%) resulted in a late miscarriage, and 4 (0.9%) resulted in an intrauterine fetal death. The prevalence of live birth was similar among the types of HFDs (P = .31). Obstetrical complications were observed in 54 (17.3%) live birth pregnancies, including vaginal bleeding (14, 4.4%), retroplacental hematoma (13, 4.1%), and thrombosis (4, 1.3%). Most deliveries were spontaneous (218, 74.1%) with a vaginal noninstrumental delivery (195, 63.3%). A neuraxial anesthesia was performed in 116 (40.4%) pregnancies, whereas general or no anesthesia was performed in 71 (16.6%) and 129 (44.9%) pregnancies, respectively. A fibrinogen infusion was administered in 28 (8.9%) deliveries. Postpartum hemorrhages were observed in 62 (19.9%) pregnancies. Postpartum venous thrombotic events occurred in 5 (1.6%) pregnancies. Women with hypofibrinogenemia were at an increased risk of bleeding during the pregnancy (P = .04). CONCLUSION: Compared with European epidemiologic data, we did not observe a greater frequency of miscarriage, while retroplacental hematoma, postpartum hemorrhage, and thrombosis were more frequent. Delivery was often performed without locoregional anesthesia. Our findings highlight the urgent need for guidance on the management of pregnancy in HFDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AfibrinogenemiaHemostaticsPostpartum HemorrhageThrombosisFemaleHumansPregnancyAbortion, SpontaneousFibrinogenGastrointestinal HemorrhageHematomaProspective StudiesRetrospective Studies

Stichwörter der Autor:innen

deliverydysfibrinogenemiahypofibrinogenemiamiscarriagepregnancy

Substanzen

FibrinogenHemostatics

Autor:innen und Institutionen

  • Gynecology Department, Gynecological Endocrinology Unit, Hospital Saint Joseph, INSERM UMR 1153, EPOPé Group, Paris, France; University Hospitals of Geneva and the Faculty of Medicine of the Geneva University, DFEA-Ob/G…
  • Gynecology Department, Bigorre Hospital Center, Tarbes, France.
  • Haemophilia Treatment Centre, University Hospital, Toulouse, France.
  • Department of Hemostasis and Transfusion, CHU Lille, Lille, France.
  • Haemophilia Treatment Centre, University Hospital, Nantes, France.
  • Haemophilia Treatment Centre, University Hospital, Montpellier, France.

Förderung

  • Novo Nordisk
  • CSL Behring

Zitieren

APA

Hugon-Rodin, J., Carrière, C., Claeyssens, S., Trillot, N., Drillaud, N., Biron-Andreani, C., Lavenu-Bombled, C., Wieland, A., Flaujac, C., Stieltjes, N., Lebreton, A., Brungs, T., Hegglin, A., Fiore, M., Desconclois, C., Gay, V., Tardy-Poncet, B., Beurrier, P., Barbay, V., …, & Casini, A. (2023). Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study. Journal of Thrombosis and Haemostasis, 21(8), 2126-2136. https://doi.org/10.1016/j.jtha.2023.04.035

Vancouver

Hugon-Rodin J, Carrière C, Claeyssens S, Trillot N, Drillaud N, Biron-Andreani C, et al. Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study. Journal of Thrombosis and Haemostasis. 2023;21(8):2126-2136. doi:10.1016/j.jtha.2023.04.035

BibTeX
@article{HugonRodin2023,
  author = {Hugon-Rodin, Justine and Carrière, Camille and Claeyssens, Ségolène and Trillot, Nathalie and Drillaud, Nicolas and Biron-Andreani, Christine and Lavenu-Bombled, Cécile and Wieland, Anna and Flaujac, Claire and Stieltjes, Natalie and Lebreton, Aurélien and Brungs, Thomas and Hegglin, Andrea and Fiore, Mathieu and Desconclois, Céline and Gay, Valérie and Tardy-Poncet, Brigitte and Beurrier, Philippe and Barbay, Virginie and Chamouni, Pierre and Maistre, Emmanuel De and Simurda, Tomas and Casini, Alessandro},
  title = {Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  volume = {21},
  number = {8},
  pages = {2126--2136},
  doi = {10.1016/j.jtha.2023.04.035}
}
Kostenlos starten →